IRIS
GABANO, Elisabetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.121
NA - Nord America 2.943
AS - Asia 533
Continente sconosciuto - Info sul continente non disponibili 8
AF - Africa 5
SA - Sud America 5
Totale 6.615
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.892
IE - Irlanda 1.082
DE - Germania 544
SE - Svezia 527
UA - Ucraina 396
IT - Italia 249
CN - Cina 248
FI - Finlandia 239
HK - Hong Kong 132
IN - India 100
CA - Canada 51
IR - Iran 36
GB - Regno Unito 26
BE - Belgio 18
TR - Turchia 11
FR - Francia 9
RU - Federazione Russa 9
EU - Europa 8
RO - Romania 8
NL - Olanda 5
EG - Egitto 4
VN - Vietnam 4
BR - Brasile 3
AL - Albania 2
AT - Austria 2
HR - Croazia 2
SG - Singapore 2
UY - Uruguay 2
ES - Italia 1
PL - Polonia 1
PT - Portogallo 1
ZA - Sudafrica 1
Totale 6.615
Salva come PNG Salva come JPEG
Città #
Dublin 1.075
Jacksonville 746
Dearborn 412
Chandler 217
Wilmington 186
Ann Arbor 146
Lawrence 134
Princeton 134
Hong Kong 132
Beijing 105
Piemonte 104
San Mateo 90
Andover 84
Ashburn 57
Bremen 50
Grafing 49
Toronto 42
Leawood 21
Cave Creek 19
Hefei 19
Helsinki 18
Monmouth Junction 18
Woodbridge 18
Zanjan 18
Nanjing 17
Brussels 16
Kunming 15
Norwalk 15
Boardman 13
Kocaeli 11
Guangzhou 10
Munich 10
Ardabil 9
Fairfield 9
Jinan 9
Augusta 8
Hebei 8
Houston 7
Udine 7
Wuhan 7
Mülheim 6
Sacramento 6
Shenyang 6
Winnipeg 6
Como 5
Fuzhou 5
Gunzenhausen 5
Ronco 5
Turin 5
Dong Ket 4
Menlo Park 4
Novara 4
Trieste 4
Villar Focchiardo 4
Asti 3
Bulandshahr 3
Cairo 3
Cambridge 3
Chengdu 3
Lucca 3
Milan 3
Moscow 3
Ningbo 3
Padova 3
Quzhou 3
Rome 3
Zhengzhou 3
Biella 2
Borgomanero 2
Changchun 2
Chaoyang 2
Des Moines 2
Düsseldorf 2
Giaveno 2
Hayward 2
Henderson 2
Huskvarna 2
Innsbruck 2
Lerici 2
Montevideo 2
Nanchang 2
New York 2
Rio de Janeiro 2
Seattle 2
Sherbrooke 2
Simi Valley 2
Taizhou 2
Torino 2
Volpedo 2
Waanrode 2
Wenzhou 2
Xian 2
Zagreb 2
Alba 1
Bangalore 1
Baotou 1
Bellinzago Novarese 1
Berlin 1
Borgomasino 1
Busalla 1
Totale 4.232
Salva come PNG Salva come JPEG
Nome #
Transition metal carbonyl clusters in biology: A futile or niche research area? 94
Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen 87
Different strategies to exploit Pt(IV) complexes as pro-drugs 86
The antiproliferative activity of dicobalt-hexacarbonyl-aspirin complex on different malignant pleural mesotelioma phenotypes 85
Cisplatin and valproate released from the bifunctional [Pt(IV)Cl2(NH3)2(valproato)2] antitumor prodrug or from liposome formulations: who does what? 84
Estradiol as Carrier For Selective Delivery of Cytotoxic Pt(II) Complexes to Cancer Cell Nuclei 82
Experimental (RP-HPLC) and theoretical (MIFs) study of the lipophilicity of a series of Pt(IV) complexes 77
Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs 76
Experimental and molecular modeling approaches to determine the lipophilicity of a Pt(IV) pro-drugs 74
Moving the paradigm in platinum-based chemotherapy from Pt(II) to Pt(IV) complexes? 74
Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer 72
Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug 69
195Pt NMR chemical shift: a chemometric approach 68
Beyond the Pt(II)-based chemotherapy: Pt(IV) complexes as oral anticancer pro-drugs 68
Pyrazolyl-diamine Pt(II) complexes bearing DNA-intercalating moieties: Synthesis, characterization and in vitro evaluation 67
Host-guest inclusion systems of Pt(IV)-bis(benzoato) anticancer drug candidates and cyclodextrins 67
Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs 67
Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells 67
A different way for the oxidation of the Pt(II) complexes 66
Bidentate and tridentate pyrazolyl-containing Pt(II) complexes: synthesis, characterization and in vitro evaluation 65
Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure-activity relationship modeling 65
Antiproliferative Activity of PtII Complexes with Carboxylated Phosphanes in Chelated or Ring-Opened Forms 64
Two are (not always) better than one: the case of bifunctional platinum(IV) drugs 63
Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 63
Application of microwave-assisted heating to the synthesis of Pt(II) complexes 62
Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin 61
Functionalized nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 61
Prediction of logP for Pt(II) and Pt(IV) complexes: Comparison of statistical and quantum-chemistry based approaches 61
Assessment of the anticancer potentiality of a new platinum nanoparticulate coniugate 60
Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: How long the organic chain should be? 60
A New Entry to Asymmetric Platinum(IV) Complexes via Oxidative Chlorination 60
Pt(IV) – histone deacetylase inhibitor conjugates for citotoxicity studies on MPM cells 59
Study of the synthesis, antiproliferative properties, and interaction with DNA and polynucleotides of cisplatin-like Pt(II) complexes containing carcinogenic polyaromatic amines 59
The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells 59
May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs? 59
Antitumor platinum(IV) pro-drugs: synthesis, characterization, cytotoxicity and QSAR analysis 58
The cisplatin-based Pt(IV)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions 58
Pt(IV) complexes as anticancer prodrugs 57
An unsymmetric cisplatin-based Pt(IV) derivative containing 2-(2-propynyl)octanoate: A very efficient multi-action antitumor prodrug candidate 57
Synthesis and characterization of cyclohexane-1R,2R-diamine-based Pt(iv) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines 57
Synthesis, characterization and antiproliferative activity of platinum(IV) derivates of picoplatin 56
Pt-195 NMR spectroscopy: A chemometric approach 56
Evaluation of Platinum–Ethacrynic Acid Conjugates in the Treatment of Mesothelioma 55
Cytotoxicity of some Pt(II)-diamine complexes: a QSAR evaluation of the effect of chelating arms and leaving groups 55
Pros and cons of bifunctional platinum drugs: two are (not always) better than one 55
Polyanionic Biopolymers for the Delivery of Pt(II) Cationic Antiproliferative Complexes 55
Solvolysis of a Series of Cisplatin-Like Complexes – Comparison between DNA-Biosensor and Conductivity Data 54
Bifunctional Pt-ethacrynic acid conjugates for malignant mesothelioma 53
Effects of dimethylsulfoxide and ethanol on the cytotoxic activity of titanocene dichloride 53
Unprecedented one-pot synthesis of an unsymmetrical cisplatin-based Pt(IV)-acetamidato complex 53
A step towards development of promising trypanocidal agents: Synthesis, characterization and in vitro biological evaluation of ferrocenyl Mannich base-type derivatives 53
A view on multi-action Pt(IV) antitumor prodrugs 53
Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity: A quantitative structure-activity relationship approach 52
Metallo-drugs in the Treatment of Malignant Pleural Mesothelioma 51
Solvolysis of Cisplatin and N-Methylated cis-[PtCl2(en)] Complexes – Comparison between DNA-Biosensor and Conductivity Data 50
Experimental determination and modeling of the lipophilicity in platinum complexes 50
Cis,cis,trans-[PtIVCl2(NH3)2(perillato)2], a dual-action prodrug with excellent cytotoxic and antimetastatic activity 50
Assessment of the in vivo antiproliferative activity of a novel platinum nanoparticulate pharmacophore 49
Bioinorganic chemistry: the study of the fate of platinum-based antitumour drugs 49
Molecular Interaction Fields vs. Quantum-Mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes 49
How to obtain Pt(IV) complexes suitable for conjugation to nanovectors from the oxidation of [PtCl(terpyridine)]+ 48
Pt(IV)/Re(I) Chitosan Conjugates as a Flexible Platform for the Transport of Therapeutic and/or Diagnostic Anticancer Agents 48
Classical Pt(II) anticancer complexes revised in view of drug targeting and delivery 47
Cellular uptake of antitumor platinum(II)-complexes evaluated by means of ICP-MS technique 47
Bifunctional Ethacrynic Acid – Pt Conjugates: In vitro Treatment of Malignant Pleural Mesothelioma 47
Anthracene-terpyridine metal complexes as new G-quadruplex DNA binders 47
Biological Activity of Enantiomeric Complexes [PtCl2L2] (L2 = Aromatic Bisphosphanes and Aromatic Diamines) 46
Synthesis of PtIV-Biomolecule Conjugates through Click Chemistry 46
Assessment of the in vivo antiproliferative activity of a novel particulate pharmacophore 45
Functionalized thymidine derivatives as carriers for the γ-emitter technetium tricarbonyl moiety 44
Study of methylation of carrier ligands in cis-[APtCl2] (A = substituted ethylenediamine) complexes 43
Poly(methylmetacrylate) (PMMA) core-shell nanospheres act as efficient pharmacophores for the antiproliferative [PtCl3(NH3)]- complex by forming ionic couples 43
The influence of temperature on antiproliferative effects, cellular uptake and DNA platination of the clinically employed Pt(II)-drugs 43
Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes 43
Synthesis And Characterization of Estradiol Derived Platinum Complexes 42
Estrogenic carriers for cytotoxic Pt(II) complexes: light and shade 42
In Vitro And In Vivo Activity Of A New Platinum Nanoparticulate Coniugate 42
Pt(II) complexes with bidentate and tridentate pyrazolyl-containing chelators: synthesis, structural characterization and biological studies 42
Pros and cons of bifunctional platinum(iv) antitumor prodrugs: two are (not always) better than one 42
A multi-methodological inquiry of the behavior of cisplatin-based Pt(IV) derivatives in the presence of bioreductants with a focus on the isolated encounter complexes 42
Relationship Among Potency (IC50), Reduction Potential (E°’) And Partition Coefficient (log Po/w) Of New Antitumour Pt(IV) Complexes 41
Organometallic compounds in the discovery of new agents against kinetoplastid-caused diseases 41
Conjugation between maleimide-containing Pt(IV) prodrugs and furan or furan-containing drug delivery vectors via Diels-Alder cycloaddition 41
Freshening up Old Methods for New Students: A Colorful Laboratory Experiment to Measure the Formation Constants of Ni(II) Complexes Containing Ethane-1,2-Diamine 41
Ethynylestradiol Derivatives as Carrier for Selective Vehiculation of Cytotoxic Pt(II)-Malonate and Radioactive Tc Fragments Towards Cancer Cells 40
log Po/w determination for a series of Pt(II) complexes by means of reverse phase HPLC 40
Electrochemical evaluation of the interaction between antitumoral titanocene dichloride and biomolecules 40
Trend in cytotoxic activity of a series of cis-[APtCl(2)] (A = ethylenediamine methylated at different positions) complexes 40
trans,cis,cis-Bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a Prodrug Candidate for the Treatment of Oxaliplatin-Refractory Colorectal Cancer 40
Platinum(II) and technetium(I) complexes anchored to ethynylestradiol: a way to drug targeting and delivery 40
The RP-HPLC measurement and QSPR analysis of log Po/w values of several Pt(II) complexes 40
Ethynylestradiol-Pt(II) complexes for selective drug targeting 39
Synthesis and characterisation of estrogenic carriers for cytotoxic Pt(II) fragments: biological activity of the resulting complexes 39
Studies on Log Po/w of Quinoxaline di-N-Oxides: A Comparison of RP-HPLC Experimental and Predictive Approaches 39
Stepwise Assembly of Platinum-Folic Acid Conjugates 39
HPLC method for the determination of monomer conversion and composition during the poly(styrene-r-methylmethacrylate) polymerization 39
Estradiol Derivatives as Carrier For Selective Vehiculation of Cytotoxic Pt(II) Complexes Towards Cancer Cells 38
Platinum(II) complexes with pyrazolyl-diamine chelators bearing DNA-binding groups”, 38
The drug targeting and delivery approach applied to Pt-antitumour complexes. A coordination point of view 38
The Relevance of Polar Surface Area (PSA) in Rationalizing Biological Properties of Several cis-Diamminemalonatoplatinum(II)-derivatives 38
Totale 5.429
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.117
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.117
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201918 0 0 0 0 0 0 0 0 0 0 6 12
2019/20201.466 6 9 131 15 237 249 324 72 156 123 138 6
2020/2021914 132 7 135 9 106 27 141 4 150 46 140 17
2021/2022979 64 17 110 114 42 0 138 27 64 23 174 206
2022/20232.176 148 89 159 48 133 204 45 125 1.085 35 69 36
2023/2024429 48 59 57 11 103 0 130 8 9 4 0 0
Totale 6.782